Stoke Therapeutics
STOK
#5004
Rank
NZ$3.20 B
Marketcap
NZ$49.01
Share price
-0.45%
Change (1 day)
-6.21%
Change (1 year)

Earnings for Stoke Therapeutics (STOK)

Earnings in 2026 (TTM): -NZ$0.43 Billion

According to Stoke Therapeutics's latest financial reports the company's current earnings are NZ$28.21 Million. In 2025 the company made an earning of -NZ$12.59 Million, an increase over its 2024 earnings that were of -NZ$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Stoke Therapeutics from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.43 Billion3286.12%
2025 -NZ$12.59 Million-92.26%
2024 -NZ$0.17 Billion-15.01%
2023 -NZ$0.2 Billion3.59%
2022 -NZ$0.19 Billion17.79%
2021 -NZ$0.16 Billion64.24%
2020 -NZ$95.51 Million61.62%
2019 -NZ$59.1 Million158.17%
2018 -NZ$22.89 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.29 Billion-35.80%๐Ÿ‡บ๐Ÿ‡ธ USA